Neurotoxins acting at synaptic sites: A brief review on mechanisms and clinical applications

K Zhou, W Luo, T Liu, Y Ni, Z Qin - Toxins, 2022 - mdpi.com
Neurotoxins generally inhibit or promote the release of neurotransmitters or bind to
receptors that are located in the pre-or post-synaptic membranes, thereby affecting …

SNARE proteins: core engines of membrane fusion in cancer

H Liu, R Dang, W Zhang, J Hong, X Li - Biochimica et Biophysica Acta (BBA …, 2024 - Elsevier
Vesicles are loaded with a variety of cargoes, including membrane proteins, secreted
proteins, signaling molecules, and various enzymes, etc. Not surprisingly, vesicle transport …

Role of SNARE proteins in tumourigenesis and their potential as targets for novel anti-cancer therapeutics

J Meng, J Wang - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2015 - Elsevier
The function of soluble N-ethylmaleimide-sensitive factor attachment protein receptors
(SNAREs) in cellular trafficking, membrane fusion and vesicle release in synaptic nerve …

SNARE modulators and SNARE mimetic peptides

M Khvotchev, M Soloviev - Biomolecules, 2022 - mdpi.com
The soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) receptor
(SNARE) proteins play a central role in most forms of intracellular membrane trafficking, a …

Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice

M Maiarù, C Leese, M Certo… - Science Translational …, 2018 - science.org
Chronic pain is a widespread debilitating condition affecting millions of people worldwide.
Although several pharmacological treatments for relieving chronic pain have been …

Engineering botulinum neurotoxins for enhanced therapeutic applications and vaccine development

C Rasetti-Escargueil, MR Popoff - Toxins, 2020 - mdpi.com
Botulinum neurotoxins (BoNTs) show increasing therapeutic applications ranging from
treatment of locally paralyzed muscles to cosmetic benefits. At first, in the 1970s, BoNT was …

New engineered-botulinum toxins inhibit the release of pain-related mediators

M Tang, J Meng, J Wang - International journal of molecular sciences, 2019 - mdpi.com
Targeted delivery of potent inhibitor of cytokine/pain-mediator into inflammatory or pain-
sensing cells is a promising avenue for treating chronic pain, a world-wide major healthcare …

Engineering of botulinum neurotoxins for biomedical applications

RP Webb - Toxins, 2018 - mdpi.com
Botulinum neurotoxins (BoNTs) have been used as therapeutic agents in the clinical
treatment of a wide array of neuromuscular and autonomic neuronal transmission disorders …

Engineering botulinum toxins to improve and expand targeting and SNARE cleavage activity

E Fonfria, M Elliott, M Beard, JA Chaddock, J Krupp - Toxins, 2018 - mdpi.com
Botulinum neurotoxins (BoNTs) are highly successful protein therapeutics. Over 40 naturally
occurring BoNTs have been described thus far and, of those, only 2 are commercially …

Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex

J Arsenault, AWM Hooper, S Gholizadeh… - Human molecular …, 2020 - academic.oup.com
Several X-linked neurodevelopmental disorders including Rett syndrome, induced by
mutations in the MECP2 gene, and fragile X syndrome (FXS), caused by mutations in the …